Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 28.6%GRADE not reported 0 · 0%Very low 0 · 0%Low 4 · 57.1%Moderate 0 · 0%High 1 · 14.3%

Summary of findings: insulin detemir vs Insulin glargin (control)

Mortality ‐ not reported · patients with type 2 diabetes mellitus

The review found no eligible studies for this question.

1 finding from 1 review

Insulin detemir versus insulin glargine for type 2 diabetes mellitus 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: insulin detemir vs Insulin glargin (control)

Quality of life and treatment satisfaction ‐ not reported · patients with type 2 diabetes mellitus

The review found no eligible studies for this question.

1 finding from 1 review

Insulin detemir versus insulin glargine for type 2 diabetes mellitus 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: insulin detemir vs Insulin glargin (control)

HbA1c (glycated haemoglobin), change · patients with type 2 diabetes mellitus

1 finding from 1 review

Insulin detemir versus insulin glargine for type 2 diabetes mellitus 2011 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 2250 participants
Low

Summary of findings: insulin detemir vs Insulin glargin (control)

Percentage of participants having at least one severe hypoglycaemic event · patients with type 2 diabetes mellitus

Insulin detemir (intervention) showed no clear difference in percentage of participants having at least one severe hypoglycaemic… compared with insulin glargin (control) (low certainty).

1 finding from 1 review

Insulin detemir versus insulin glargine for type 2 diabetes mellitus 2011 · Cochrane Headline outcomes only
RR 0.82 [0.51, 1.32]
4 studies · 2252 participants
Low

Summary of findings: insulin detemir vs Insulin glargin (control)

Percentage of participants having at least one hypoglycaemic event · patients with type 2 diabetes mellitus

Insulin detemir (intervention) showed no clear difference in percentage of participants having at least one hypoglycaemic event compared with insulin glargin (control) (low certainty).

1 finding from 1 review

Insulin detemir versus insulin glargine for type 2 diabetes mellitus 2011 · Cochrane Headline outcomes only
RR 0.98 [0.92, 1.05]
4 studies · 2252 participants
Low

Summary of findings: insulin detemir vs Insulin glargin (control)

Weight gain · patients with type 2 diabetes mellitus

1 finding from 1 review

Insulin detemir versus insulin glargine for type 2 diabetes mellitus 2011 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 2250 participants
High

Summary of findings: insulin detemir vs Insulin glargin (control)

Injection‐site reaction Rates of patients · patients with type 2 diabetes mellitus

Insulin detemir (intervention) may leads to higher percentage of participants having at least one injection site reaction compared with insulin glargin (control) (low certainty).

1 finding from 1 review

Insulin detemir versus insulin glargine for type 2 diabetes mellitus 2011 · Cochrane Headline outcomes only
RR 3.31 [1.13, 9.73]
4 studies · 2252 participants
Low